Home›Companies›Food & Agriculture›Strella

Strella Biotechnology, Inc.

Produce sensors and monitoring tools for growers, shippers, distributors and retailers.

Updated Nov 9, 2026·Latest SEC filing Aug 14, 2026·Suggest an edit

About Strella

Strella is a private company based in Seattle, Washington. It has reported $10,679,804 raised in three offerings on Form D since April 2020. Its chief executive is Katherine Sizov.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 29, 2026Aug 14, 2026$1,761,591of $3.2M target35$50,331Equity, OptionsRule 506(b)Form D ↗
Feb 21, 2024Sep 10, 2024$5,602,000fully sold17$329KDebtRule 506(b)Form D ↗
Apr 2, 2020Apr 17, 2020$3,316,213fully sold17$195KEquity, Series Seed Preferred Stock.Rule 506(b)Form D ↗
Total, three offerings$10,679,804

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Strella's Form D filed Aug 14, 2026.

Katherine Sizov
Katherine Sizov
Founder, CEO and director

Earlier filings also listed Nolan Paul (director, last listed Sep 2024), Eric Linn (director, last listed Sep 2024), Jacob Jordan (executive officer, director and promoter, last listed Apr 2020) and Brett Topche (director, last listed Apr 2020).

Sources

  1. SECStrella Biotechnology, Inc. filing history
  2. CompanyAbout